Welcome to our dedicated page for ASCEND WELLNESS HOLDNGS A news (Ticker: AAWH), a resource for investors and traders seeking the latest updates and insights on ASCEND WELLNESS HOLDNGS A stock.
Ascend Wellness Holdings, Inc. (OTCQX: AAWH) is a vertically integrated, multi-state cannabis operator with a significant presence in Illinois, Maryland, Massachusetts, Michigan, Ohio, New Jersey, and Pennsylvania. The company is dedicated to providing superior products and services in the cannabis industry, leveraging state-of-the-art cultivation facilities to grow award-winning strains and produce a curated selection of products tailored for retail and wholesale customers.
Ascend Wellness Holdings focuses on simplifying the cannabis experience with its effect-based categorization of products, ensuring that customers' unique needs are met with consistency and quality. The company operates several brands, including Ozone, Ozone Reserve, Simply Herb, Common Goods, Tunnel Vision, and Royale, catering to a variety of consumer preferences.
Recent achievements include a reported net revenue of $142.4 million for Q1 2024, marking a 25% increase year-over-year. Additionally, the company generated $32.5 million in Adjusted EBITDA, reflecting a 39% increase from the previous year. As of March 31, 2024, Ascend Wellness Holdings had $72.9 million in cash and cash equivalents, demonstrating financial robustness and a positive cash flow from operations for the fifth consecutive quarter.
Ascend Wellness Holdings continues to expand its footprint, with recent openings of dispensaries in Cincinnati, Ohio, and Monaca, Pennsylvania, bringing its total to 36 dispensaries. The company's strategic focus includes densifying its retail presence and expanding wholesale penetration while driving innovation and productivity across its operations. This growth strategy is supported by key partnerships and long-term supply agreements, such as those recently secured in Maryland.
The company’s commitment to social equity is evident through initiatives like the Ascend CO-LAB for Social Equity, which fosters a more inclusive and sustainable industry by addressing social disparities caused by the war on drugs.
Led by CEO John Hartmann, Ascend Wellness Holdings is poised for continued success and is actively preparing for potential federal cannabis reform that could further enhance its market position. Hartmann's recent acquisition of 192,500 shares of Class A common stock underscores his confidence in the company's strategic direction and growth potential.
For more information about Ascend Wellness Holdings and to stay updated on their latest developments, visit www.awholdings.com.
Ascend Wellness Holdings (AAWH) reported its Q2 2024 financial results, showing 15.1% year-over-year growth in net revenue to $141.5 million. The company achieved a 32.9% increase in Adjusted EBITDA to $28.3 million, representing a 20.0% margin. AWH generated positive cash flow from operations for the sixth consecutive quarter, with approximately $32 million in Q2. However, the company faced challenges, including retail headwinds in some markets. As a result, AWH revised its full-year guidance, now anticipating net revenue growth between 11-13% and Adjusted EBITDA growth between 5-10% for 2024 compared to the previous year. The company also successfully refinanced $215 million of its existing term loan and opened new dispensaries in Pennsylvania and New Jersey.
Ascend Wellness Holdings (AAWH) has successfully closed a $235 million private placement of 12.75% Senior Secured Notes due 2029. The notes were issued at 94.75% of face value. AWH used the net proceeds, along with cash on hand, to prepay $215 million of its existing term loan. This strategic refinancing is expected to enhance the company's financial flexibility and strengthen its balance sheet.
The remaining $60 million of the term loan will continue at 9.5% interest and can be repaid at par between February and August 2025. The new notes are senior secured obligations, payable semi-annually, and mature on July 16, 2029. They are secured by substantially all assets of the company and certain subsidiaries. Seaport Global Securities acted as lead financial advisor and sole placement agent for the notes.
Ascend Wellness Holdings (AAWH) has secured $235 million in Senior Secured Notes with a 12.75% coupon and 5-year term. The company plans to use the net proceeds, along with cash on hand, to prepay $215 million of its existing term loan. This refinancing is expected to enhance AWH's financial flexibility and strengthen its balance sheet.
Key points:
- Notes to be issued at 94.75% of face value
- Maturity date: July 16, 2029
- Interest payable semi-annually
- Secured by substantially all assets of the company and certain subsidiaries
- $60 million remaining on existing term loan to be carried through at 9.5% interest
The offering is expected to close around July 16, 2024, subject to customary conditions.
Ascend Wellness Holdings (AWH) will hold a conference call on Monday, August 5, 2024, at 8:30 AM ET to discuss its second quarter 2024 financial results. The call can be accessed through a dial-in number or via a live webcast on the Investor Relations section of their website. The replay of the call will be available afterward. AWH is a leading multi-state, vertically integrated cannabis operator with operations in Illinois, Maryland, Massachusetts, Michigan, Ohio, New Jersey, and Pennsylvania. They produce and distribute a variety of in-house branded cannabis products.
Ascend Wellness Holdings (AAWH) announced the relocation of its Montclair dispensary to a new location in Wharton, New Jersey, set to open on June 28, 2024. This new facility spans approximately 3,000 square feet and features 13 sales terminals, six kiosks, two ATMs, and ample parking. The dispensary will serve both medical and adult-use cannabis customers, offering a wide range of products including flowers, vaporizers, concentrates, ingestibles, topicals, and accessories, along with a drive-thru service. The move aims to cater to the growing New Jersey market and enhance customer convenience. A grand opening celebration will be held on June 28, 2024, allowing attendees to explore the new store and meet the Ascend team.
Ascend Wellness Holdings (CSE: AAWH-U.CN, OTCQX: AAWH), a multi-state marijuana operator, has opened its fourth medical dispensary in Cranberry, Pennsylvania, marking its 37th location across seven states. This expansion highlights the company's commitment to the growing medical market in Pennsylvania. The Cranberry dispensary, located near I-76 and I-79, offers a variety of products including whole flower, vaporizers, concentrates, ingestibles, topicals, and accessories. The grand opening takes place on June 21, 2024. The dispensary spans 2,000 square feet within a 6,500 square foot building, featuring 11 terminals, four kiosks, and on-site ATMs for efficient service. Ascend also introduced the Ascenders Club loyalty program, rewarding patients for purchases and referrals. The dispensary is open seven days a week, with varying hours.
Ascend Wellness Holdings (AAWH), a multi-state cannabis operator, announced the appointment of Julie Francis to its Board of Directors, effective June 3, 2024. This expansion increases the board members from six to seven. Francis, recognized as an independent director by SEC and NYSE standards, brings extensive experience from her roles at Schwan's Company, Constellation Brands, and Coca-Cola Refreshments. Her appointment strengthens AWH's governance practices and aligns with its growth objectives. Executive Chair, Abner Kurtin, highlighted her expertise in the consumer goods sector as a valuable asset for the company.
Ascend Wellness Holdings, Inc. (AAWH) announced its participation in upcoming investor conferences, including the Needham Technology, Media, & Consumer Conference on May 16, 2024, Canaccord Genuity's Global Cannabis Conference on May 23, 2024, and the KCSA Virtual Cannabis Conference on June 5, 2024. The company's top executives will be participating in various panels and one-on-one investor meetings at these events. AWH is a multi-state cannabis operator with assets in several states, producing and distributing a variety of branded products. For more details, visit their website.
AWH ANNOUNCES Q1 2024 FINANCIAL RESULTS: Ascend Wellness Holdings, Inc. reported $142.4M Net Revenue in Q1 2024, a 25% YoY increase and 2% QoQ increase. Adjusted EBITDA was $32.5 million, a 39% YoY increase. The company generated positive cash flow. Retail revenue increased 15.1% YoY. Net loss was $18.2 million. Cash and cash equivalents were $72.9 million. AWH opened two dispensaries, secured operating agreements with two partner dispensaries, and operationalized a new facility. The company plans revenue growth of 12-15% and adjusted EBITDA increase of 17-22% compared to 2023.
Ascend Wellness Holdings, Inc. (AWH) supports the DEA's decision to move cannabis from Schedule I to Schedule III of the CSA, marking a significant step in cannabis reform. This change is expected to bring benefits like tax relief, improved access, funding opportunities, research advancements, and potential up-listing for AWH. The company looks forward to further developments and celebrates the decision's positive impact on stakeholders.
FAQ
What is the current stock price of ASCEND WELLNESS HOLDNGS A (AAWH)?
What is the market cap of ASCEND WELLNESS HOLDNGS A (AAWH)?
What is Ascend Wellness Holdings, Inc.?
Which states does Ascend Wellness Holdings operate in?
What brands does Ascend Wellness Holdings produce?
How did Ascend Wellness Holdings perform financially in Q1 2024?
What are some recent developments at Ascend Wellness Holdings?
What is the Ascend CO-LAB for Social Equity?
Who leads Ascend Wellness Holdings?
What is the strategic focus of Ascend Wellness Holdings?
How does Ascend Wellness Holdings ensure product quality?
Where can I find more information about Ascend Wellness Holdings?
